Kalorama Information, a part of Science and Medicine Group, has announced that it has published its 25th report since the acquisition of the company by Science and Medicine Group. Since November, the firm has reported on food safety testing, infectious disease, Latin American Markets, molecular diagnostics and many other markets.
“Experts in sequencing, liquid biopsy, mass spectrometry are now available to us, as is an extensive network of clinical instrument placements and survey capabilities that can provide insights.”
Science and Medicine Group (then called Bioinformatics, Inc.) purchased Kalorama Information on November 1st, 2018. Previously the division was owned by MarketResearch.com
“Kalorama Information has been enhanced by the synergies present in an environment with healthcare and test instrument publishing partners,” said Bruce Carlson, Publisher of Kalorama Information and Senior Vice President of Publications for Science and Medicine Group. “Experts in sequencing, liquid biopsy, mass spectrometry are now available to us, as is an extensive network of clinical instrument placements and survey capabilities that can provide insights.”
Upcoming reports include a complete survey of laboratories using sequencing conducted by an expert with 2 decades of experience in biotech market research, a survey of clinical diagnostics customers relating customer experience and preferences. In August, the firm will publish its 12th Edition of the World Market for In Vitro Diagnostics.
“Our reports are quite different from the factory market research publishers that publish on cars this week, healthcare next week. Kalorama are based on real industry knowledge, experts put to the task, a focus on vendor actions versus academic modeling of industries.”
Kalorama’s website is available at www.kaloramainformation.com